LONE TREE, Colo., Jan. 8, 2026 /PRNewswire/ -- Cochlear, the global leader in implantable hearing solutions, is proud to announce that the groundbreaking Nucleus® Nexa® System is now available to ...
LONE TREE, Colo., July 8, 2025 /PRNewswire/ -- Cochlear Limited (ASX: COH), the global leader in implantable hearing solutions, today announced the U.S Food and Drug Administration (FDA) approval of ...
Cochlear Ltd. heard good news from the U.S. FDA, as the agency approved its next-generation cochlear implant, the Nucleus Nexa System, the first smart cochlear implant system. Cochlear expects to ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Atrium Health Wake Forest Baptist is the first and only ...
The news: Hearing device maker Cochlear has received regulatory approval from the US Food and Drug Administration (FDA) for its new Nucleus Nexa System, and its Nucleus Kanso 3 and Kanso 3 Nexa sound ...
The Cochlear Ltd (ASX: COH) share price is in focus today after the hearing implant leader posted a modest 1% lift in sales revenue to $1,176 million for the half year ended December 2025, but ...
Six months after becoming the first patient in the United States to receive a newly FDA-approved cochlear implant system, 18-month-old Nene Gudavadze is responding to sound, dancing to music, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results